Part-Time

Invasive Cardiac Associate Electrophysiology PD

Posted on 5/16/2026

Brown University Health

Brown University Health

1-10 employees

Remote behavioral health care platform analytics

Compensation Overview

$61.30 - $77.78/hr

Providence, RI, USA

In Person

Per diem, day shift; on-site at Rhode Island Hospital.

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • Graduate of an accredited physician assistant or nurse practitioner program.
  • Current Rhode Island nurse practitioner or physician assistant license that includes prescriptive privileges.
  • Current Rhode Island DEA license required.
  • Certified by the American Nurses Credentialing Center (ANCC), the American Academy of Nurse Practitioners (AANP), or the Commission on the Accreditation of Physician Assistants to practice in the expanded role.
  • Certification by the American Heart Association in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS).
  • Demonstrated knowledge and skills necessary to provide care to patients and families with consideration of aging processes, human development stages and cultural patterns in each step of the care process.
  • Must have patient care services, procedures, and privileges approved by the sponsoring physician.
Responsibilities
  • Obtains and records medical histories and physical examinations in the electronic health record in a timely manner.
  • Records pertinent progress and procedural notes and develops individualized treatment plans.
  • Performs pre-admission testing for patients undergoing invasive cardiac procedures and obtains anesthesia consultations when appropriate.
  • Responsible for monitoring pre-and post-procedural care in the Progressive Care Unit (PCU).
  • Initiates orders for inpatient admissions and completes discharge summaries, requesting follow-up appointments, completing medication reconciliation, and referring to cardiac rehab when appropriate for same day discharge patients.
  • Participates in the education of patients, families, and caregivers regarding any procedures, post-procedural care, and expected outcomes and progress.
  • Responsible for initiating life-saving measures in emergency situations.
  • Responsible for routine and problematic cardiac device evaluations and reprogramming, evaluating and treating arrhythmias, evaluating, and treating other symptomatic cardiac patients both urgent and non-urgent, and preparing patients for upcoming device upgrades and generator changes including extractions and revisions.
  • Actively works toward obtaining IHBRE cardiac device certification within first 5 years of employment.
  • First assist with invasive and non-invasive cardiac procedures performed by the cardiac proceduralist in the electrophysiology laboratory.
  • Independently performs loop recorder implants, explants and direct current cardioversions when deemed proficient by Director of electrophysiology services.
  • Responsible for meeting minimum standards for maintaining proficiency for bi-annual recredentialing.
  • Responsible for recording procedural notes and submitting for payer reimbursement.
  • Initiates inpatient electrophysiology consultations at The Miriam Hospital and communicates findings to electrophysiology attendings.
  • Provides educational and liaison support to the primary care team members.
  • Facilitates scheduling inpatient electrophysiology procedures.
  • Participates in the care of electrophysiology outpatient ambulatory care patients by providing consults and re-evaluations in addition to urgent outpatient evaluations.
  • May perform other duties as requested by the attending physician within the Nurse Practitioner/Physician Assistant scope of practice.
  • Participates in quality improvement teams, clinical research projects and other committees, as needed.
  • Maintains quality assurance, safety, and environmental and infection control in accordance with established hospital/department policies, procedures, and objectives.
Desired Qualifications
  • Two years of clinical cardiology experience as a nurse practitioner or physician assistant is preferred
Brown University Health

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Your Connections

People at Brown University Health who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Multi-million dollar annual investments expand academic-clinical integration.
  • Rhode Island Hospital and Bradley specialize in behavioral health training.
  • Outpatient networks align with home-based behavioral care coordination.

What critics are saying

  • TriZetto cyber incident disrupts Brown University Health billing March 2026.
  • Lyra Health erodes employer behavioral health market share in New England.
  • Medicaid redetermination disenrolls 20-30% behavioral patients ongoing.

What makes Brown University Health unique

  • STAT program offers free certification for entry-level healthcare roles.
  • Exclusive teaching affiliate of Warren Alpert Medical School at Rhode Island Hospital.
  • Community Health Institute delivers Rhode Island-focused proactive care initiatives.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Paid Sick Leave

Productivity Bonus

Stock Options

Company Equity

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Loan Assistance

Professional Development Budget

Education allowance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Commuter Benefits

Meal Benefits

Medical Insurance

Life Insurance

Disability Insurance

Company News

PBN
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

PBN
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

PBN
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

PBN
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System

INACTIVE